Neuraxis (NRXS) director boosts stake with stock award and dividends
Rhea-AI Filing Summary
Neuraxis, INC director Aharon Gil reported three acquisitions of Common Stock of NRXS. On 2026-08-13, he received 43,930 shares at $6.28 per share as compensation for serving as an independent director. On 2026-07-29, he and Rosalind Master Fund L.P. received 2,226 and 40,068 shares, respectively, as stock dividends on their Series B Preferred Stock, based on accrued 8.5% cumulative dividends divided by $2.38. The 40,068-share position is reported as indirect ownership through Rosalind Advisors, Inc., with beneficial ownership disclaimed except for each party’s pecuniary interest, and total indirect holdings after these transactions are 548,123 shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 86,224 shares
Net Buy
3 txns
Insider
Aharon Gil
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock F2 | 43,930 | $6.28 | $276K |
| Grant/Award | Common Stock F1 | 2,226 | -- | -- |
| Grant/Award | Common Stock F1, F3 | 40,068 | -- | -- |
Holdings After Transaction:
Common Stock — 80,058 shares (Direct);
Common Stock — 548,123 shares (Indirect, By Rosalind Advisors, Inc., the advisor to the Rosalind Master Fund L.P.)
Footnotes (3)
- F1. The number of shares of common stock issued as a dividend on the Series B Preferred Stock to Rosalind Master Fund L.P. and the Reporting Person were 40,068 and 2,226, respectively, and was determined by dividing the accrued and unpaid 8.5% cumulative dividends on the respective Series B Preferred Stock (from the investment date, through the applicable record or conversion date) by $2.38.
- F2. These shares of common stock were issued to the reporting person as compensation for services as independent director of the Issuer.
- F3. Each Reporting Persons disclaims beneficial ownership over the shares except to the extent of his or its respective pecuniary interest therein.
Key Figures
Director compensation grant: 43,930 shares
Grant price per share: $6.28 per share
Dividend shares to reporting person: 2,226 shares
+4 more
7 metrics
Director compensation grant
43,930 shares
Common Stock awarded on 2026-08-13 for services as independent director
Grant price per share
$6.28 per share
Value assigned to 43,930-share director compensation award on 2026-08-13
Dividend shares to reporting person
2,226 shares
Common Stock dividend issued on Series B Preferred Stock to the reporting person
Dividend shares to Rosalind Master Fund L.P.
40,068 shares
Common Stock dividend issued on Series B Preferred Stock to Rosalind Master Fund L.P.
Cumulative dividend rate
8.5%
Accrued and unpaid cumulative dividends on Series B Preferred Stock used to calculate stock dividends
Dividend conversion divisor
$2.38
Accrued cumulative dividends on Series B Preferred Stock divided by $2.38 to determine share amounts
Indirect holdings after transactions
548,123 shares
Total indirect Common Stock holdings reported following the 40,068-share dividend issuance
Key Terms
Series B Preferred Stock, 8.5% cumulative dividends, pecuniary interest, indirect ownership
4 terms
Series B Preferred Stock financial
"dividend on the Series B Preferred Stock to Rosalind Master Fund L.P."
Series B preferred stock is a type of ownership share issued by a company that offers certain advantages over common stock, such as priority in receiving dividends or assets if the company is sold or liquidated. It is typically issued after an initial round of funding, making it a way for investors to support a company's growth while gaining some protections and benefits. This stock matters to investors because it often provides a more secure investment position with potential for future growth.
8.5% cumulative dividends financial
"determined by dividing the accrued and unpaid 8.5% cumulative dividends"
pecuniary interest financial
"disclaims beneficial ownership over the shares except to the extent of his or its respective pecuniary interest"
indirect ownership financial
"ownership: By Rosalind Advisors, Inc., the advisor to the Rosalind Master Fund L.P."
FAQ
What transactions did NRXS director Aharon Gil report on this Form 4?
Aharon Gil reported three acquisitions of Neuraxis (NRXS) Common Stock. These include a 43,930-share stock award for board service and stock dividends of 2,226 and 40,068 shares issued on Series B Preferred Stock holdings.
How were the Series B Preferred stock dividends for NRXS calculated?
The stock dividends were based on 8.5% cumulative dividends on Series B Preferred Stock. Accrued and unpaid dividends from the investment date through the relevant date were divided by $2.38 to determine the Common Stock share amounts of 2,226 and 40,068.
What are Aharon Gil’s indirect NRXS holdings after these transactions?
After the reported acquisitions, indirect holdings total 548,123 shares of Neuraxis Common Stock. These shares are held through an entity relationship noted as Rosalind Advisors, Inc., acting as advisor to Rosalind Master Fund L.P.
Were these NRXS transactions executed under a Rule 10b5-1 trading plan?
The filing indicates the Rule 10b5-1 checkbox is not marked. This means the reported acquisitions, including the stock award and dividend-related shares, were not affirmatively identified as being made pursuant to a Rule 10b5-1 trading plan.
AI-generated analysis. How Rhea-AI works. Not financial advice.
